Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001104659-22-028660 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-01 | 2022-02-25 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | S - Sale+OE | $28.47 | -23.0K | 118.0K | -16% | -$654.9K |
| D | 2022-03-01 | 2022-02-25 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $14.95 | +23.0K | 129.0K | +22% | +$343.9K |
| D | 2022-03-01 | 2022-02-25 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $0.00 | -23.0K | 25.1K | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-25 | S | D | 12,000 | $28.95 | 106,042 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-25 | M | A | 23,000 | $14.95 | 129,042 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-25 | S | D | 11,000 | $27.95 | 118,042 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2022-02-25 | M | D | 23,000 | $0.00 | 25,074 | D | $14.95 · — to 2025-03-26 | 23,000 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |